Europe Viral Vector And Plasmid Dna Manufacturing Market Size & Outlook

The viral vector and plasmid dna manufacturing market in Europe is expected to reach a projected revenue of US$ 4,753.6 million by 2030. A compound annual growth rate of 20% is expected of Europe viral vector and plasmid dna manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,323.4
Forecast, 2030 (US$M)
$4,753.6
CAGR, 2024 - 2030
20%
Report Coverage
Europe

Europe viral vector and plasmid dna manufacturing market, 2018-2030 (US$M)

Europe

Related Markets

Europe viral vector and plasmid dna manufacturing market highlights

  • The Europe viral vector and plasmid dna manufacturing market generated a revenue of USD 1,323.4 million in 2023.
  • The market is expected to grow at a CAGR of 20% from 2024 to 2030.
  • In terms of segment, adeno-associated virus (aav) was the largest revenue generating vector type in 2023.
  • Adeno-associated virus (AAV) is the most lucrative vector type segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.


Europe data book summary

Market revenue in 2023USD 1,323.4 million
Market revenue in 2030USD 4,753.6 million
Growth rate20% (CAGR from 2023 to 2030)
Largest segmentAdeno-associated virus (aav)
Fastest growing segmentAdeno-associated virus (AAV)
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAdeno-associated virus (AAV), Lentivirus, Adenovirus, Retrovirus, Plasmids
Key market players worldwideMerck KGaA, Lonza Group Ltd, FUJIFILM Holdings Corp, Thermo Fisher Scientific Inc, Catalent Inc, WuXi Biologics (Cayman) Inc, Takara Bio Inc, Batavia Biosciences, Miltenyi Biotec, Revvity Inc, BioNTech SE ADR, Astellas Pharma Inc, Biomarin Pharmaceutical Inc, Regenxbio Inc


Other key industry trends

  • In terms of revenue, Europe region accounted for 24.8% of the global viral vector and plasmid dna manufacturing market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 4,119.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Viral Vector And Plasmid DNA Manufacturing Market Scope

Viral vector and plasmid dna manufacturing market segmentation & scope
Adeno-associated virus (AAV)
Lentivirus
Adenovirus
Retrovirus
Plasmids
Others
Vector Amplification & Expansion
Vector Recovery/Harvesting
Purification
Fill-finish
Antisense & RNAi
Gene Therapy
Cell Therapy
Vaccinology
Research Applications
Pharmaceutical and Biopharmaceutical Companies
Research Institutes
Cancer
Genetic Disorders
Infectious Diseases
Others

Viral Vector And Plasmid DNA Manufacturing Market Companies

Name Profile # Employees HQ Website

Europe viral vector and plasmid dna manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral vector and plasmid dna manufacturing market will help companies and investors design strategic landscapes.


Adeno-associated virus (aav) was the largest segment with a revenue share of 20.15% in 2023. Horizon Databook has segmented the Europe viral vector and plasmid dna manufacturing market based on adeno-associated virus (aav), lentivirus, adenovirus, retrovirus, plasmids covering the revenue growth of each sub-segment from 2018 to 2030.


Europe held the second-largest share in the market in 2022, following North America, and is estimated to grow at a CAGR of xx% over the forecast period. The market growth can be attributed to an increase in research funding and the presence of local key market players in this region.

The number of biopharmaceutical companies is growing in Europe owing to increasing investments. For instance, in February 2022, the UK pledged around USD 192 million to the Coalition for Epidemic Preparedness Innovations for boosting vaccine development.

Reasons to subscribe to Europe viral vector and plasmid dna manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe viral vector and plasmid dna manufacturing market databook

  • Our clientele includes a mix of viral vector and plasmid dna manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe viral vector and plasmid dna manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe viral vector and plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe viral vector and plasmid dna manufacturing market size, by country, 2018-2030 (US$M)

Europe Viral Vector And Plasmid DNA Manufacturing Market Outlook Share, 2023 & 2030 (US$M)

Europe viral vector and plasmid dna manufacturing market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more